• UCLA Health
  • myUCLAhealth
  • School of Medicine
Research

Research Programs

Research
  • Back to Division of Digestive Diseases
  • About Us
    • From the Chiefs
    • Clinical Trials and Studies
    • DDW Abstracts
    • Research Council
  • Themes
    • Brain-Gut Microbiome
    • Cancer
    • Inflammatory Bowel Disease
    • Interventional Endoscopy
    • Liver Disease
    • Metabolism and Obesity
  • Centers
    • Center for Inflammatory Bowel Diseases
    • Center for Obesity and METabolic Health (COMET)
    • Center for Systems Biomedicine
    • CURE: Digestive Diseases Research Center
    • G. Oppenheimer Center for Neurobiology of Stress and Resilience
  • Labs and Programs
    • Anton Laboratory
    • Beaven Laboratory
    • Benhammou Laboratory
    • Dong Laboratory
    • Han Laboratory
    • Hemostasis Research
    • Health Services Research
    • Hepatology Research
    • Hsiao Laboratory
    • Interventional Endoscopy Research
    • Jacob Laboratory
    • Jacobs Laboratory
    • Kaunitz Laboratory
    • Limketkai Laboratory
    • May Laboratory
    • Mulugeta Laboratory
    • Patel Laboratory
    • Pisegna Laboratory
    • Pothoulakis Laboratory
    • Rozengurt Laboratory
    • Saab Laboratory
    • Sachs Laboratory
    • Sternini Laboratory
    • Tabibian Laboratory
    • Taché Laboratory
    • Videlock Laboratory
  • Training Programs
    • Fellowship Seed Grants
    • GI Fellowship Program
    • NIH T32 Training Grant
    • Specialty Training and Advanced Research (STAR) Program
  • Research Faculty
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

Research Programs

Labs and Programs

Labs and Programs

Labs and Programs

  • Anton Laboratory
  • Beaven Laboratory
  • Benhammou Laboratory
  • Dong Laboratory
  • Han Laboratory
  • Hemostasis Research
  • Health Services Research
  • Hepatology Research
  • Hsiao Laboratory
  • Interventional Endoscopy Research
  • Jacob Laboratory
  • Jacobs Laboratory
  • Kaunitz Laboratory
  • Limketkai Laboratory
  • May Laboratory
  • Mulugeta Laboratory
  • Patel Laboratory
  • Pisegna Laboratory
  • Pothoulakis Laboratory
  • Rozengurt Laboratory
  • Saab Laboratory
  • Sachs Laboratory
  • Sternini Laboratory
  • Tabibian Laboratory
  • Taché Laboratory
  • Videlock Laboratory
  • Anton Laboratory
  • Beaven Laboratory
  • Benhammou Laboratory
  • Dong Laboratory
  • Han Laboratory
  • Hemostasis Research
  • Health Services Research
  • Hepatology Research
  • Hsiao Laboratory
  • Interventional Endoscopy Research
  • Jacob Laboratory
  • Jacobs Laboratory
  • Kaunitz Laboratory
  • Limketkai Laboratory
  • May Laboratory
  • Mulugeta Laboratory
  • Patel Laboratory
  • Pisegna Laboratory
  • Pothoulakis Laboratory
  • Rozengurt Laboratory
  • Saab Laboratory
  • Sachs Laboratory
  • Sternini Laboratory
  • Tabibian Laboratory
  • Taché Laboratory
  • Videlock Laboratory
  1. Home
  2. Research
  3. Labs and Programs
  4. Pisegna Laboratory

Pisegna Laboratory

Share this

Pisegna Molecular Genetics and Physiology Laboratory


Key investigators

  • Joseph Pisegna, MD
  • Patrizia M. Germano, MD
  • Suwan Oh, PhD

Funding

  • NIH/NCI M3LD Study subaward - “Gut-related markers and hepatocellular cancer risk in a multi-ethnic cirrhotic cohort" 
  • VA Merit Review - Gastrointestinal Hormonal Regulation of Obesity Project F-7219R
  • VA Cooperative Study CSP 577 Confirm Trial
  • NIH NIDDK U01 Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers (CSCPDPC -CCs -RFA-DK-14-027) - “Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes”
  • Diacomp NIH NIDDK/Emory University Pisegna, PI - “Role of the Vagus Nerve in Regulating Diabetes and Metabolic Syndrome"

Research funding

  • BX004560-01, 01/01/201912/31/2023, Veterans Affairs Merit Review, CMA: Cancer Stem Cells in the Pathogenesis and Treatment of Colorectal Cancer
  • 1R21 CA225623-01, 03/01/2018-02/29/2020, NIH/NCI Identification of Microbial Biomarkers for Hepatocellular Carcinoma in a Multi-Ethnic Population of Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
  • R01 CA204145 07/22/2016-06/30/2021, NIH/NCI Gut-Related Markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort
  • U01, 01/01/2016-12/30/2021, NIH/NIDDK Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers (CSCPDPC -CCs -RFA-DK-14-027)
  • CSP 577 Confirm Trial 10/01/2012-09/30/2027, VA Cooperative Study investigating FIT vs screening colonoscopy

Current research projects

  • Evaluation of the role of high protein dietary intervention in metabolic syndrome
  • Evaluation of the role of high protein dietary intervention in hepatic steatosis
  • Role of PACAP in metabolic syndrome
  • Role of PACAP and VIP in mouse models of colitis
  • Role of VIP in metabolic syndrome and hepatic steatosis
  • GWAS studies in colonic polyps, NAFLD and NASH
  • Pathophysiology, epidemiology and prevention of pancreatogenic diabetes
  • Pathophysiology of gastrin and VIP on the regulation of gastric and renal function

Future research directions

  • Genetic basis for metabolic syndrome, NAFLD and NASH
  • Pathophysiological basis for hormone and receptors to regulate gastrointestinal function
  • Neuroendocrine tumor-pathophysiology and genetic basis
  • Gastrointestinal regulation of renal physiologic function

Key publications

  1. Van C, Condro MC, Lov K, Zhu R, Ricaflanca PT, Ko HH, Diep AL, Hoang AQ, Pisegna J, Rohrer H, Waschek JA. PACAP/PAC1 Regulation of Inflammation via the Sympathetic Nervous System in a Model of Multiple Sclerosis. J Mol Neurosci. 2018 Jul 30. doi: 10.1007/s12031-018-1137-8. PMID:30058008
  2. Jacobs JP, Dong TS, Agopian V, Lagishetty V, Sundaram V, Noureddin M, Ayoub WS, Durazo F, Benhammou J, Enayati P, Elashoff D, Goodman MT, Pisegna J, Hussain S. Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study. Hepatol Res. 2018 Jun 20. doi: 10.1111/hepr.13207. PMID:29923681
  3. Mohapatra SS, Batra SK, Bharadwaj S, Bouvet M, Cosman B, Goel A, Jogunoori W, Kelley MJ, Mishra L, Mishra B, Mohapatra S, Patel B, Pisegna JR, Raufman JP, Rao S, Roy H, Scheuner M, Singh S, Vidyarthi G, White J. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions. Dig Dis Sci. 2018 May;63(5):1123-1138. doi: 10.1007/s10620-018-5000-0. Epub 2018 Mar 23. Review.PMID:29572615
  4. Benhammou JN, Dong TS, May FP, Kawamoto J, Dixit R, Jackson S, Dixit V, Bhattacharya D, Han SB, Pisegna JR. Race affects SVR12 in a large and ethnically diverse hepatitis C-infected patient population following treatment with direct-acting antivirals: Analysis of a single-center Department of Veterans Affairs cohort. Pharmacol Res Perspect. 2018 Feb 22;6(2):e00379. doi: 10.1002/prp2.379. 2018 Apr.
  5. Ehrlich D, Jamaluddin N, Pisegna J, Padua D. A Challenging Case of Severe Ulcerative Colitis following the Initiation of Secukinumab for Ankylosing Spondylitis. Case Rep Gastrointest Med. 2018 Feb 15;2018:9679287. PMID:29666723
  6. Vu JP, Luong L, Parsons WF, Oh S, Sanford D, Gabalski A, Lighton JR, Pisegna JR, Germano PM. Long-Term Intake of a High-Protein Diet Affects Body Phenotype, Metabolism, and Plasma Hormones in Mice. J Nutr. 2017 Dec;147(12):2243-2251. doi: 10.3945/jn.117.257873. Epub 2017 Oct 25.PMID:29070713
  7. Aby ES, Dong TS, Kawamoto J, Pisegna JR, Benhammou JN. Impact of sustained virologic response on chronic kidney disease progression in hepatitis C. World J Hepatol. 2017 Dec 28;9(36):1352-1360. doi: 10.4254/wjh.v9.i36.1352.PMID: 29359019
  8. Wang L, Jacobs JP, Lagishetty V, Yuan PQ, Million M, Reeve JR, Pisegna J and Tache Y High protein diet promotes sensitity to cholecystokinin and shifts the cecal microbiome without altering brain inflammation in diet induced obesity in rats. Am J Physiol Regul Integr Comp Physiol 2017 Jul 19.
  9. Calais J, Czernin J, Eiber M, Fendler WP, Gartmann J, Heaney A, Hendifar A, Pisegna J, Hecht JR, Wolin E, Slavik R, Gupta P, Quon A, Schiepers C, Allen-Auerbach M, Herrmann K. Most Intended Management Changes after 68-Ga-DOTATATE PET/CT are Implemented J Nucl Med. 2017 May 4. pii: jnumed.117.192450. doi: 10.2967/jnumed.117.192450. PMID:28473600
  10. Li R, Yang J, Saffari A, Jacobs J, Baek KI, Hough G, Larauche MH, Ma J, Jen N, Moussaoui N, Zhou B, Kang H, Reddy S, Henning SM, Campen MJ, Pisegna J, Li Z, Fogelman AM, Sioutas C, Navab M, Hsiai TK. Ambient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites. Sci Rep. 2017 Feb 17;7:42906. PMID: 28211537
  11. Benhammou JN, Phan J, Lee H, Ghassemi K, Parsons W, Grody WW, Pisegna JR. A Sodium Channel Myotonia Presenting with Intermittent Dysphagia as a Manifestation of a Rare SCN4A Variant. J Mol Neurosci. 2016 Dec 23. doi: 10.1007/s12031-016-0878-5.PMID:28012096.
  12. Padua D, Mahurkar-Joshi S, Law I, Polytarchou C, Vu J, Pisegna J, Shih D, Iliopolous D, and Pothoulakis C A Long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation. American Journal of Physiology 2016 311(3):G446-57.
  13. Wang J, Benhammou JN, Ghassemi K, Kim S, Pisegna JR (2017) Endoscopic Ultrasound-Guided Fine Needle Aspiration Accurately Diagnoses Smaller Pancreatic Neuroendocrine Tumors Compared To Computer Tomography-Guided Fine Needle Aspiration. Gastroenterol Pancreatol Liver Disord 4(2): 1-7.
  14. Padua D, Vu JP, Germano PM, Pisegna JR. The Role of Neuropeptides in Mouse Models of Colitis. J Mol Neurosci. 2016 Jun;59(2):203-10. doi: 10.1007/s12031-015-0688-1. Epub 2015 Dec 8. Review.PMID:26646243
  15. Vu JP, Goyal D, Luong L, Oh S, Sandhu R, Norris J, Parsons W, Pisegna JR, Germano P. PACAP intraperitoneal treatment suppresses appetite and food intake via PAC1 receptor in mice, by inhibiting ghrelin and increasing GLP-1 and leptin. Am J Physiol Gastrointest Liver Physiol. 2015 Sep 3:ajpgi.00190.2015. doi: 10.1152/ajpgi.00190.2015. [Epub ahead of print]
  16. Vu JP, Larauche M, Flores M, Luong L, Norris J, Oh S, Liang LJ, Waschek J, Pisegna JR, Germano PM. Regulation of Appetite, Body Composition, and Metabolic Hormones by Vasoactive Intestinal Polypeptide (VIP). J Mol Neurosci. 2015 Jun;56(2):377-87.
  17. Vu JP, Million M, Larauche M, Luong L, Norris J, Waschek JA, Pothoulakis C, Pisegna JR, Germano PM. Inhibition of vasoactive intestinal polypeptide (VIP) induces resistance to dextran sodium sulfate (DSS)-induced colitis in mice. J Mol Neurosci. 2014 Jan;52(1):37-47.

Past GI research fellows

  • Joon Ki Choi, MD
  • Jihane Benhammou, MD, PhD
  • Tien S. Dong, MD, PhD
  • Arpana Gupta, PhD
  • Deepinder Goyal, MD
  • Noam Jacobs, MD, PhD
  • Sang Le, MD
  • Edward Lee, MD, MS
  • Edward Lew, MD, MS
  • Elizabeth Marcus, MD
  • Rong-Ming Lyu, PhD
  • Hank Wang, MD, MS
  • Emily Whang, MD
  • Ning Zeng, MD, PhD

Current GI Research Fellows

  • Coming soon

More information

  • Visit CURE: Digestive Diseases Research Center
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth